Resveratrol treatment regulated Bcl-xL and NF-κB protein levels in an in vitro Alzheimer’s disease model, and protected rat pheochromocytoma cells, PC12, against Aβ-induced oxidative stress [122]. This evidence concerns the gene BCL2L1 and early-onset autosomal dominant Alzheimer disease.